Synapse - Hiroyoshi Kunimoto

Hiroyoshi Kunimoto

Groups

Research Focus

Former Employee. Human Oncology and Pathogenesis Program; Research Scholar

Recent additions – View all

Cooperative epigenetic remodeling by TET2 loss and NRAS mutation drives myeloid transformation and MEK inhibitor sensitivity
Journal Article

Kunimoto, H.; Meydan, C.; Nazir, A.; Whitfield, J.; Shank, K.; Rapaport, F.; Maher, R.; Pronier, E.; Meyer, S. C.; Garrett-Bakelman, F. E.; more...
Cancer Cell (2018)

Fulltext@MSK | Save
Aid is a key regulator of myeloid/erythroid differentiation and DNA methylation in hematopoietic stem/progenitor cells
Journal Article

Kunimoto, H.; McKenney, A. S.; Meydan, C.; Shank, K.; Nazir, A.; Rapaport, F.; Durham, B.; Garrett-Bakelman, F. E.; Pronier, E.; Shih, A. H.; more...
Blood (2017)

Fulltext@MSK | Save
Epigenetic identity in AML depends on disruption of nonpromoter regulatory elements and is affected by antagonistic effects of mutations in epigenetic modifiers
Journal Article

Glass, J. L.; Hassane, D.; Wouters, B. J.; Kunimoto, H.; Avellino, R.; Garrett-Bakelman, F. E.; Guryanova, O. A.; Bowman, R.; Redlich, S.; Intlekofer, A. M.; more...
Cancer Discovery (2017)

Fulltext@MSK | Save

Co-authors at MSK

4

Levine
3

Nazir
3

Pronier
3

Rapaport
3

Shank
3

Shih
1

Bowman
1

Durham
1

Glass
1

Guryanova
1

Intlekofer
1

Maher
1

Mckenney
1

Redlich
1

Tallman
1

Thompson
1

Whitfield

Types of Work

Publications